Bal Research Foundation Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 1.00 M
as on 16-11-2024
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit 18.81%
(FY 2023)
- Ebitda 1.57%
(FY 2023)
- Net Worth -31.51%
(FY 2023)
- Total Assets %
(FY 2023)
About Bal Research Foundation
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Shailesh Siroya and Ravindrakumar Kothari serve as directors at the Company.
- CIN/LLPIN
U73100KA2014NPL076995
- Company No.
076995
- Company Classification
Private Not For Profit Company
- Incorporation Date
29 Oct 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Bal Research Foundation?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailesh Siroya  | Director | 22-Dec-2014 | Current |
| Ravindrakumar Kothari | Director | 18-Jul-2023 | Current |
Financial Performance and Corporate Structure Insights of Bal Research Foundation.
Bal Research Foundation, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 18.81% increase in profit. The company's net worth observed a substantial decline by a decrease of 31.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bal Research Foundation?
In 2023, Bal Research Foundation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Lifezen Healthcare Private LimitedActive 10 years 1 month
Shailesh Siroya and Ravindrakumar Kothari are mutual person
Balance Clinics LlpActive 10 years 7 monthsShailesh Siroya and Ravindrakumar Kothari are mutual person
- Golden Drugs Private LimitedActive 12 years 3 months
Shailesh Siroya and Ravindrakumar Kothari are mutual person
- Aurum Research & Analytical Solutions Private LimitedActive 1 year 4 months
Shailesh Siroya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bal Research Foundation?
Unlock and access historical data on people associated with Bal Research Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bal Research Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bal Research Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
